The protective effect showed up even at doses too low to cause meaningful weight loss, according to the Cedars-Sinai-led laboratory research.
Recap by typeshit. Full story at Medical Xpress on MSN.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
Inc. looks at Walmart's employee drug coverage, which pays for the GLP-1 drugs while leaving out their use for weight loss.
People on weight loss drugs are being urged to shop around, with research suggesting some are paying more than they need to for pills or injections.
Loading…